MaxCyte (NASDAQ:MXCT – Get Free Report) and Bullfrog AI (NASDAQ:BFRGW – Get Free Report) are both healthcare companies, but which is the better stock? Analyst RatingsThis is a breakdown of recent ratings and target prices for MaxCyte and Bullfrog AI, as provided by MarketBeat.com. Given MaxCyte’s stronger consensus rating and higher probable upside, equities analysts clearly believe MaxCyte is more favorable than Bullfrog AI. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MaxCyte $33.03 million 3.83 -$44.63 million ($0.37) -3.19 Bullfrog AI $116,670.00 N/A N/A N/A N/ABullfrog AI has lower revenue, but higher earnings than MaxCyte. Net Margins Return on Equity Return on Assets MaxCyte -121.16% -20.03% -17.14% Bullfrog AI N/A N/A N/ASummaryMaxCyte beats Bullfrog AI on 6 of the 9 factors compared between the two stocks.